Estimate Recalculated Jun 3, 2025 09:02PM EST
Amy W Schulman has an estimated net worth of $16.5 Million. This is based on reported shares across multiple companies, which include Fractyl Health, Inc., Zoetis Inc., ALNYLAM PHARMACEUTICALS, INC., PFIZER INC, BIND Therapeutics, Inc, Hudson Executive Investment Corp., Hudson Executive Investment Corp. II, IRONWOOD PHARMACEUTICALS INC, Blue Buffalo Pet Products, Inc., SQZ Biotechnologies Co, Cyclerion Therapeutics, Inc., and Arsanis, Inc..
Amy W Schulman's CIK is 0001438226
2013 was Amy W Schulman's most active year for acquiring shares with 25 total transactions. Amy W Schulman's most active month to acquire stocks was the month of January. 2013 was Amy W Schulman's most active year for disposing of shares, totalling 19 transactions. Amy W Schulman's most active month to dispose stocks was the month of April. 2024 saw Amy W Schulman paying a total of $3,120,185.00 for 88,728 shares, this is the most they've acquired in one year. In 2012 Amy W Schulman cashed out on 218,990 shares for a total of $2,958,138.20, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!